Archive for August, 2013

MedChemComm call for papers: Carbohydrate themed issue

MedChemComm themed issue: Carbohydrates

Guest Editors: Sylvie Garneau-Tsodikova (University of Kentucky, USA) and Timor Baasov (Technion-Israel Institute of Technology, Israel)

Submission Deadline: 28th February 2014

Submissions are now open for a high-profile themed issue on Carbohydrates, due for publication in MedChemComm in summer 2014. The scope of the issue covers all areas of carbohydrate chemistry and biology which are relevant to drug discovery.

New research in MedChemComm is published as Concise Articles: flexible articles that have no strict page limits or formatting requirements. Manuscripts can be submitted in any reasonable format using our submission system. Template is not required. Please indicate that it is for the Carbohydrates themed issue in the comments to the editor field. The level of quality of this issue will be high, and all manuscripts will undergo the journal’s normal peer review process.

The deadline for submissions to the themed issue is 28th February 2014, although submissions before this date are of course welcomed.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Q2 top 10 for MedChemComm

Please take a look at the top 10 most accessed MedChemComm articles for the second quarter of 2013:

Metabolism-guided drug design
Antonia F. Stepan, Vincent Mascitti, Kevin Beaumont and Amit S. Kalgutkar
Med. Chem. Commun., 2013, 4, 631-652
DOI: 10.1039/C2MD20317K

Synthesis and antiproliferative activity of some 3-(pyrid-2-yl)-pyrazolines
Alexander Ciupa, Paul A. De Bank, Mary F. Mahon, Pauline J. Wood and Lorenzo Caggiano
Med. Chem. Commun., 2013, 4, 956-961
DOI: 10.1039/C3MD00077J

Minisci reactions: Versatile CH-functionalizations for medicinal chemists
Matthew A. J. Duncton
Med. Chem. Commun., 2011, 2, 1135-1161
DOI: 10.1039/C1MD00134E

A critical assessment of modeling safety-related drug attrition
Daniel Muthas, Scott Boyer and Catrin Hasselgren
Med. Chem. Commun., 2013, 4, 1058-1065
DOI: 10.1039/C3MD00072A

Increasing small molecule drug developability in sub-optimal chemical space
Timothy J. Ritchie, Simon J. F. Macdonald, Simon Peace, Stephen D. Pickett and Christopher N. Luscombe
Med. Chem. Commun., 2013, 4, 673-680
DOI: 10.1039/C3MD00003F

Recent applications of multicomponent reactions in medicinal chemistry
Paul Slobbe, Eelco Ruijter and Romano V. A. Orru
Med. Chem. Commun., 2012, 3, 1189-1218
DOI: 10.1039/C2MD20089A

On the origins of drug polypharmacology
Xavier Jalencas and Jordi Mestres
Med. Chem. Commun., 2013, 4, 80-87
DOI: 10.1039/C2MD20242E

Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications
Paul C. Trippier and Christopher McGuigan
Med. Chem. Commun., 2010, 1, 183-198
DOI: 10.1039/C0MD00119H

Silver nanoparticles—the real “silver bullet” in clinical medicine?
Kenneth K. Y. Wong and Xuelai Liu
Med. Chem. Commun., 2010, 1, 125-131
DOI: 10.1039/C0MD00069H

The use of phosphate bioisosteres in medicinal chemistry and chemical biology
Thomas S. Elliott, Aine Slowey, Yulin Ye and Stuart J. Conway
Med. Chem. Commun., 2012, 3, 735-751
DOI: 10.1039/C2MD20079A

We very much welcome your thoughts and comments below:

Interested in submitting your own work to MedChemComm? Submit online today, or email us with your suggestions!

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)